Gayathri Publishers
  • Home
  • Antibodies
  • Assay
  • Blocking
  • 4 Host
  • 96T
  • Positive
  • array
  • precipitation
  • Premix
  • Preps
  • primers
  • probe
  • profiling
  • Pure
  • Recombinant
  • Purification
  • purified
  • Rabbit
  • profile
  • COVID-19
  • nCOVID-19 test
  • Coronavirus test
  • procalcitonin (PCT)
  • Rapid test
  • 2019-nCoV IgG
  • immuno-filtration techniques
  • immuno-chromatographic
  • immuno-dot
  • agglutination
  • gelsosomo’s crown point
  • gelson’s thousand oaks
  • gelson’s rancho mirage
  • gelson’s weekly flyer
  • Prehabilitation in Thoracic Cancer Surgery: From Research to Standard of Care
  • CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research
  • Panbio Rapid/Simple test for COVID-19
  • Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool.
  • Quantile regression for survival data in modern cancer research: expanding statistical tools for precision medicine.
  • Contact Us

Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.

April 30, 2021 Claudia Coleman 4 Host, 96T, array, Assay, Blocking, Main, Positive, precipitation, Premix, Preps, primers, probe, profiling, Pure, Purification, purified, Quantile regression for survival data in modern cancer research: expanding statistical tools for precision medicine., Rabbit, Recombinant, The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research. 0

Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.

Going from bench to bedside is a simplified description of translational analysis, with the final word aim being to enhance the well being standing of mankind. Tumor endothelial cells (TECs) carry out angiogenesis to help the expansion, institution, and dissemination of tumors to distant organs. TECs have numerous options that distinguish them from regular endothelial cells, which embody alterations in gene expression patterns, greater angiogenic and metabolic actions, and drug resistance tendencies. The particular traits of TECs improve the vulnerability of tumor blood vessels towards antiangiogenic therapeutic methods.

Therefore, aside from being a viable therapeutic goal, TECs would act as a greater mediator between the bench (i.e., angiogenesis analysis) and the bedside (i.e., scientific software of medicine found via analysis). Exploitation of TEC traits might reveal unidentified methods of enhancing and monitoring antiangiogenic remedy within the remedy of most cancers, that are mentioned on this overview.The utility of 18-fluordesoxyglucose positron emission tomography ([18F]-FDG-PET) mixed with laptop tomography or magnetic resonance imaging (MRI) in gastric most cancers stays controversial and a rationale for affected person choice is desired.

This examine goals to determine a preclinical patient-derived xenograft (PDX) primarily based [18F]-FDG-PET/MRI protocol for gastric most cancers and evaluate totally different PDX fashions relating to tumor progress and FDG uptake. The relationships between irritation and tumor are very complicated: irritation possibly induce most cancers, then again, most cancers cells would launch inflammatory cytokines into microenvironment round them. These outcomes suggest that producing CRC tumor fashions on the person affected person stage is value contemplating particularly for superior tumor circumstances with a dismal prognosis.

So it’s laborious to establish most cancers and irritation, particularly early tumor and continual irritation in scientific sufferers screening. Conditional reprogrammed cells (CRCs) permit establishing a secure cell cultures of regular and tumor epithelial cells from sufferers’ tissues. This new strategy of residing tissue tradition can retain the genotype and phenotype of tumor cells and regular cells, and notice cell progress. It can present dependable cell tradition detection to display early most cancers from continual irritation and even establishing fashions in vivo for most cancers chemotherapy-resistant sufferers.

Female BALB/c nu/nu mice had been implanted orthotopically and subcutaneously with gastric most cancers PDX. [18F]-FDG-PET/MRI scanning protocol analysis included totally different tumor sizes, FDG doses, scanning intervals, and organ-specific uptake. FDG avidity of comparable PDX circumstances had been in contrast between ortho- and heterotopic tumor implantation strategies. Microscopic and immunohistochemical investigations had been carried out to verify tumor progress and correlate the glycolysis markers glucose transporter 1 (GLUT1) and hexokinase 2 (HK2) with FDG uptake.

Research Progress of 70 kDa Ribosomal Protein S6 Kinase (P70S6K) Inhibitors as Effective Therapeutic Tools for Obesity, Type II Diabetes and Cancer.

At current, ailments akin to weight problems, kind Ⅱ diabetes and most cancers have introduced severe well being issues, that are intently associated to mTOR pathway. 70 kDa ribosomal protein S6 kinase (p70S6K), as a major downstream effector of mTOR, mediates protein synthesis, RNA processing, glucose homeostasis, cell progress and apoptosis. Inhibiting the perform of p70S6K can cut back the chance of weight problems which helps to deal with dyslipidemia, improve insulin sensitivity, and prolong the life span of mammals. Therefore, p70S6K has change into a possible goal for the remedy of those ailments. So far, besides for the primary p70S6K particular inhibitor PF-4708671 developed by Pfizer and LY2584702 developed by Lilai, all of them are in preclinical analysis.

This paper briefly introduces the overall scenario of p70S6K and critiques their inhibitors in recent times, that are primarily labeled into two classes: pure compounds and artificial compounds. In explicit, their inhibitory actions, structure-activity relationships (SARs) and mechanisms are highlighted.The present examine aimed to assemble competing endogenous RNA (ceRNA) regulation community and develop two precision drugs predictive instruments for colorectal most cancers (CRC).Differentially expressed (DE) analyses had been carried out between CRC tissues and regular tissues. In a multivariate evaluation mannequin, success solely correlated positively with the nodal standing N1 and mutations within the genes Ok-Ras and B-Raf.

Then a Fifteen-mRNA signature was developed to foretell general survival for CRC sufferers. Concordance indexes had been 0.817, 0.838, and 0.825 for 1-, 2- and 3-year general survival. Patients with excessive danger scores have worse OS in contrast with sufferers with low danger scores.The present examine supplied deeper understanding of prognosis-related ceRNA regulatory community for CRC. Two precision drugs predictive instruments named Smart Cancer Survival Predictive System and Gene Survival Analysis Screen System had been constructed for CRC. These two precision drugs predictive instruments can present worthwhile treasured particular person mortality danger prediction earlier than surgical procedure and enhance the individualized remedy decision-making.

Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.

Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research.

Over the time interval from 2006 to 2017, consecutive sufferers operated on on the University Medical Center Rostock participated within the complete biobanking and tumor-modelling strategy generally known as the HROC assortment. Samples had been collected utilizing strict customary working procedures together with blood (serum and lymphocytes), tumor tissue (very important and snap frozen), and adjoining regular epithelium. Patient and tumor knowledge together with classification, molecular kind, scientific final result, and outcomes of the mannequin institution are the important pillars.

Cancer Antigen 15-3 (CA 15-3) Breast Tumor Standard Grade

GWB-87C810 GenWay Biotech 50000 Unit Ask for price

Cancer Antigen 125 (CA 125) Standard Grade

GWB-A9985A GenWay Biotech 50000 Unit Ask for price

Cancer Antigen 125 (CA 125) Standard Grade

GWB-565817 GenWay Biotech 25000 Unit Ask for price

Cancer Antigen 19-9 (CA 19-9) Standard Grade

GWB-EECE0C GenWay Biotech 50000 Unit Ask for price

Cancer Antigen 72-4 (CA 72-4) Standard Grade

GWB-626B6B GenWay Biotech 10 KU Ask for price

Cancer Antigen 72-4 (CA 72-4) Standard Grade

GWB-254330 GenWay Biotech 50000 Unit Ask for price

Cancer Antigen 19-9 (CA 19-9) Standard Grade

GWB-1CA918 GenWay Biotech 50000 Unit Ask for price

CA15-3 Cancer Antigen (CA15-3, Breast Tumor Protein)

MBS651681-10KUnits MyBiosource 10KUnits
EUR 1050

CA15-3 Cancer Antigen (CA15-3, Breast Tumor Protein)

MBS651681-5x10KUnits MyBiosource 5x10KUnits
EUR 4565

CA15-3 Cancer Antigen (Breast Cancer)

MBS651656-50KUnits MyBiosource 50KUnits
EUR 1890

CA15-3 Cancer Antigen (Breast Cancer)

MBS651656-5x50KUnits MyBiosource 5x50KUnits
EUR 8345

Human Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody Pair Kit (with Standard)

MBS2103664-10x96Tests MyBiosource 10x96Tests
EUR 1480

Human Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody Pair Kit (with Standard)

MBS2103664-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1600

Human Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody Pair Kit (with Standard)

MBS2103664-5x96Tests MyBiosource 5x96Tests
EUR 935

Human Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody Pair Kit (with Standard)

MBS2103664-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 1010

Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody Pair Kit (with Standard)

MBS2103665-10x96Tests MyBiosource 10x96Tests
EUR 1480

Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody Pair Kit (with Standard)

MBS2103665-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1600

Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody Pair Kit (with Standard)

MBS2103665-5x96Tests MyBiosource 5x96Tests
EUR 935

Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Antibody Pair Kit (with Standard)

MBS2103665-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 1010

Human Breast Tumor Cancer Cells

ABC-HP013X AcceGen 1 vial Ask for price
Description: Human breast cancer cells are isolated from human invasive ductal breast carcinoma sample. Human breast cancer cells are positive for pan-Cytokeratin, MGB-1 and MUC-1. CD90 staining shows that cultures are free of fibroblasts in 99%.

Cancer Antigen 15-3 (CA 15-3) Low Cross Grade

GWB-E47BC0 GenWay Biotech 10000 Unit Ask for price

Rat Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100267-10x96Tests MyBiosource 10x96Tests
EUR 1595

Rat Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100267-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1715

Rat Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100267-5x96Tests MyBiosource 5x96Tests
EUR 1005

Rat Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100267-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 1080

Rat Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100292-10x96Tests MyBiosource 10x96Tests
EUR 1595

Rat Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100292-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1715

Rat Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100292-5x96Tests MyBiosource 5x96Tests
EUR 1005

Rat Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100292-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 1080

Human Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100265-10x96Tests MyBiosource 10x96Tests
EUR 1410

Human Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100265-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1530

Human Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100265-5x96Tests MyBiosource 5x96Tests
EUR 895

Human Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100265-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 970

Mouse Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100266-10x96Tests MyBiosource 10x96Tests
EUR 1445

Mouse Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100266-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1570

Mouse Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100266-5x96Tests MyBiosource 5x96Tests
EUR 915

Mouse Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody Pair Kit (with Standard)

MBS2100266-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 990

Human Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100290-10x96Tests MyBiosource 10x96Tests
EUR 1410

Human Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100290-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1530

Human Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100290-5x96Tests MyBiosource 5x96Tests
EUR 895

Human Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100290-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 970

Mouse Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100291-10x96Tests MyBiosource 10x96Tests
EUR 1515

Mouse Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100291-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1640

Mouse Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100291-5x96Tests MyBiosource 5x96Tests
EUR 960

Mouse Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody Pair Kit (with Standard)

MBS2100291-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 1035

Breast tumor antigen (CA-15-3) Antibody, Concentrate

MAB521C Innovex 0.2ml
EUR 455

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2)

MBS6507054-02mg MyBiosource 0.2mg
EUR 700

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2)

MBS6507054-5x02mg MyBiosource 5x0.2mg
EUR 3010

Cancer Antigen 15-3 (CA 15-3) Cell Culture Low Cross Grade

GWB-553B7B GenWay Biotech 10000 Unit Ask for price

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (HRP)

MBS6244012-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (HRP)

MBS6244012-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (PE)

MBS6244545-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (PE)

MBS6244545-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (AP)

MBS6241881-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (AP)

MBS6241881-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (APC)

MBS6242414-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (APC)

MBS6242414-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (FITC)

MBS6243479-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (FITC)

MBS6243479-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (Biotin)

MBS6242946-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (Biotin)

MBS6242946-5x01mL MyBiosource 5x0.1mL
EUR 4310

Human Cancer Antigen CA15-3 Antigen Grade

GWB-C54ECC GenWay Biotech 50000 Unit Ask for price

Human Cancer Antigen CA15-3 Antigen Grade

MBS318065-50KUnits MyBiosource 50KUnits
EUR 2585

Human Cancer Antigen CA15-3 Antigen Grade

MBS318065-5x50KUnits MyBiosource 5x50KUnits
EUR 11460

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 490)

MBS6245611-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 490)

MBS6245611-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 550)

MBS6246144-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 550)

MBS6246144-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 650)

MBS6246677-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 650)

MBS6246677-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 405)

MBS6245078-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 405)

MBS6245078-5x01mL MyBiosource 5x0.1mL
EUR 4310

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 750)

MBS6247210-01mL MyBiosource 0.1(mL
EUR 990

BRCA2 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 2) (MaxLight 750)

MBS6247210-5x01mL MyBiosource 5x0.1mL
EUR 4310

Human Cancer PrimaCell™4: Breast Tumor Cells

2-96027 CHI Scientific 1 Kit
EUR 1321.11

Breast Cancer Antigen CA15-3 Enzyme Immunoassay Test Kit

GWB-150A4D GenWay Biotech ELISA_Kits Ask for price

Breast tumor antigen (CA-15-3) Antibody, Ready-To-Use

MAB521P Innovex 5ml
EUR 445

Breast cancer and normal tissue array with stage and grade info

BR8012 TissueArray each
EUR 306
Description: Breast cancer and normal tissue array with stage and grade info, 40 cases/80 cores, replaced by BR8014

Human Cancer Tissue Preparation Buffer 4: Breast Tumor Cells

9-80027 CHI Scientific 1 x 100 ml
EUR 280.9

Breast Cancer-Associated Antigen BRCAA1 (BRCAA1) Antibody

20-abx148333 Abbexa
  • Ask for price
  • Ask for price
  • 50 ug
  • 100 ug

Human tumor marker CA549 for breast cancer ELISA Kit

SL3271Hu Sunlong 96 Tests
EUR 468

Breast fibroadenoma, breast tissue and breast cancer array, including pathology grade, TNM and clinical stage, 71 cases/80 cores

BR8010 BioCoreUSA row: 8; column: 10; cores: 80; cases: 71
EUR 306
Description: Breast fibroadenoma, breast tissue and breast carcinoma microarray, containing 7 cases of normal breast, 3 adjacent normal breast tissue, 20 fibroadenoma, 10 invasive lobular carcinoma, 30 invasive ductal carcinoma and 10 matched or matched lymph node metastatic carcinoma, single core per block

Human Cancer PrimaCell™4: Breast Tumor Cells Growth Medium

9-46027 CHI Scientific 5 x 100 ml
EUR 289.9

Human Cancer/Testis Antigen 1B (CTAG1B) Antibody Pair Kit (with Standard)

MBS2104021-10x96Tests MyBiosource 10x96Tests
EUR 1480

Human Cancer/Testis Antigen 1B (CTAG1B) Antibody Pair Kit (with Standard)

MBS2104021-10x96TestsMBS2090685AbPairsSupportPack110x96Tests MyBiosource 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1600

Human Cancer/Testis Antigen 1B (CTAG1B) Antibody Pair Kit (with Standard)

MBS2104021-5x96Tests MyBiosource 5x96Tests
EUR 935

Human Cancer/Testis Antigen 1B (CTAG1B) Antibody Pair Kit (with Standard)

MBS2104021-5x96TestsMBS2090685AbPairsSupportPack15x96Tests MyBiosource 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 1010

Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade

MBS319684-50KUnits MyBiosource 50KUnits
EUR 440

Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade

MBS319684-5x50KUnits MyBiosource 5x50KUnits
EUR 1800

Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade

MBS319694-50KUnits MyBiosource 50KUnits
EUR 515

Cancer Antigen 19-9 (Gastrointestinal Cancer) Calibrator Grade

MBS319694-5x50KUnits MyBiosource 5x50KUnits
EUR 2155

Gastrointestinal Cancer Antigen (CA 19-9), antigen grade

CA1991-N-10 Alpha Diagnostics 10 KU
EUR 634.8

(untagged)-Human breast cancer antigen NY-BR-1.1 mRNA, partial cds

SC315066 Origene Technologies GmbH 10 µg Ask for price

Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores

FMG252 BioCoreUSA row: 4; column: 6; cores: 24; cases: 12
EUR 78
Description: Breast carcinoma with matched breast tissue microarray, containing 12 cases breast carcinoma with matched cancer adjacent breast tissue, duplicate cores per case

Breast cancer with breast tissue array, including pathology grade, TNM and clinical satge, 31 cases/50 cores

BRE502 BioCoreUSA row: 6; column: 9; cores: 50; cases: 31
EUR 162
Description: Breast carcinoma with breast tissue microarray, containing 16 cases of invasive carcinoma of no special type, 1 invasive lobular carcinoma, 3 medullary carcinoma, 4 invasive carcinoma, 1 metaplastic carcinoma, plus 25 adjacent normal or cancer adjacent breast tissue (19 matched with cancer), single core per block

Cancer Antigen 125 (CA 125) Low Cross Grade

GWB-87F2DB GenWay Biotech 10000 Unit Ask for price

Breast cancer tissue array (pathology grade:1,2,3), including pathology grade, TNM and clinical stage, 45 cases/90 cores

BR901 BioCoreUSA row: 9; column: 10; cores: 90; cases: 45
EUR 270
Description: Breast invasive carcinoma of no special type tissue microarray, containing 40 cases of invasive carcinoma of no special type, 5 adjacent normal breast tissue, duplicate core per case

OPMA04167-50KIU - Human Cancer Antigen CA15-3 Antigen Grade Protein

OPMA04167-50KIU Aviva Systems Biology 50KU
EUR 2999

Breast cancer tissue array, with adjacent normal tissue and cancer adjacent breast tissue, including pathology grade,TNM and clinical stage, 45 cases/63 cores

FMG631 BioCoreUSA row: 7; column: 9; cores: 63; cases: 45
EUR 270
Description: Breast invasive carcinoma of no special type tissue microarray, containing 21 cases of invasive carcinoma of no special type, with adjacent normal and cancer adjacent breast tissue (18 matched with cancer), single core per block

Cancer Antigen CA50, Calibrator Grade Protein

GWB-T00050 GenWay Biotech 50KU Ask for price

Breast Cancer and 8 types of tumor (middle advanced stage)tissue array

BR20838a TissueArray each
EUR 474
Description: Breast Cancer and 8 types of tumor (middle advanced stage)tissue array, including pathology grade, TNM/stage with IHC Her-2 results, 118 cases/208 cores (core size 1.5mm), replacing BR20838

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b

BR1504c BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
EUR 306
Description: Breast carcinoma with breast tissue microarray, containing 70 cases of invasive ductal carcinoma, 4 adjacent normal breast tissue and 1 breast tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b

BR2085c BioCoreUSA row: 13; column: 16; cores: 208; cases: 188
EUR 546
Description: Breast carcinoma with breast tissue microarray, containing 144 cases of invasive carcinoma of no special type, 24 invasive lobular carcinoma, 1 breast tissue, 19 adjacent normal breast tissue, single core per case of carcinoma, duplicate cores per case of breast tissue and adjacent normal breast tissue

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c

FBR087d BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
EUR 66
Description: Breast carcinoma with breast tissue microarray, containing 3 cases of invasive carcinoma of no special type, 1 invasive lobular carcinoma, 2 breast tissue, quadruple cores per case, 2 serial sections, divided into two identical 12 core arrays for testing different antibody dilutions

Cancer Antigen CA242 (Gastrointestinal Cancer) Calibrator Grade Protein

GWB-T00229 GenWay Biotech 50KU Ask for price

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401307-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401307-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401308-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401308-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401309-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401309-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401310-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401310-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401311-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401311-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401312-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401312-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401313-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401313-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401314-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401314-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401315-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401315-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401316-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401316-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401317-01mL MyBiosource 0.1mL
EUR 1040

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6401317-5x01mL MyBiosource 5x0.1mL
EUR 4540

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6264464-01mL MyBiosource 0.1mL
EUR 970

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6264464-5x01mL MyBiosource 5x0.1mL
EUR 4220

MUC1 (Mucin-1, MUC-1, Breast Carcinoma-associated Antigen DF3, Cancer Antigen 15-3, CA 15-3, Carcinoma-associated Mucin, Episialin, H23AG, Krebs von den Lungen-6, KL-6, PEMT, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, Tumor-ass

MBS6264465-01mL MyBiosource 0.1mL
EUR 970
×

Overall, 149 patient-derived xenografts with 34 major and 35 secondary cell strains had been efficiently established and embody all colorectal carcinoma anatomic websites, grading and staging sorts, and molecular lessons. The HROC assortment represents one of many largest mannequin assortments from consecutive scientific colorectal carcinoma (CRC) circumstances worldwide. Statistical evaluation recognized quite a lot of clinicopathological and molecular elements related to mannequin success in univariate evaluation. Several of them not recognized earlier than embody localization, mutational standing of Ok-Ras and B-Raf, MSI-status, and grading and staging parameters.

 

 

  • particles crowded together
  • particles flow
  • particles for justice
  • particles gif
  • particles in urine
  • particles in urine female
  • particles in wood smoke
  • particles life
  • particles linguistics
  • particles list
  • particles lyrics
  • particles mod
  • particles of a liquid
  • particles of dark matter
  • particles of faith trasancos
  • particles particles
  • particles png
  • particles react npm
  • particles smaller than quark
  • particles synonym
  • particles.js
  • particleshop
  • particleshop corel
  • ria kista
  • ria kits run 2019
  • rna definition
  • rna fish
  • rna meaning
  • rna polymerase
  • rna primer
  • rna replication
  • rna reset
  • rna sequence
  • rna sequencing
  • rna splicing
  • rna structure
  • rna vaccine
  • rna vaccine wiki
  • rna velocity
  • rna viruses
  • rna vs dna
  • rna world
  • rna-seq
  • rnac
  • rnahybrid
  • rnai
  • rnascope
  • rnation login
  • rnation.riteaid.com
  • serums 101
  • serums 2019
  • serums 76
  • serums anoka menu
  • serums bar
  • serums def
  • serums fo76
  • serums for acne
  • serums for hair
  • serums for hair growth
  • serums for men
  • serums for sensitive skin
  • serums for wrinkles
  • serums in anoka
  • serums in anoka mn
  • serums mn
  • serums osrs
  • serums peru
  • serums ulta
  • serums vs creams
  • serums with glycerin
  • serums with spf
  • serums.com
  • serumstat
  • test kits cdc
  • test kits contaminated
  • test kits contaminated uk
  • test kits contaminated with coronavirus
  • test kits contaminated with covid-19
  • test kits contaminated with covid19
  • test kits fda
  • test kits for coronavirus
  • test kits for covid-19
  • test kits for ionizer systems
  • test kits for mdma
  • test kits for meth
  • test kits for mold
  • test kits for molly
  • test kits for nursing homes
  • test kits for ph
  • test kits for pools
  • test kits news
  • test kits ny
  • test kits usa
  • vector virus definition
  • vector virus example
  • vector virus introduction
  • vector virus relationship
  • victor virus
  • victor virus cartoonmania
  • virus
  • virus by state
  • virus by state numbers
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer ResearchPrevious

CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research

Bioelectric Impedance Vector Analysis (BIVA) in Breast Cancer Patients: A Tool for Research and Clinical Practice.Next

Bioelectric Impedance Vector Analysis (BIVA) in Breast Cancer Patients: A Tool for Research and Clinical Practice.

Categories

  • 4 Host
  • 96T
  • array
  • Assay
  • Blocking
  • Blog
  • Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool.
  • Main
  • Positive
  • precipitation
  • Premix
  • Preps
  • primers
  • probe
  • profile
  • profiling
  • Pure
  • Purification
  • purified
  • Quantile regression for survival data in modern cancer research: expanding statistical tools for precision medicine.
  • Rabbit
  • Recombinant
  • The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research.

Recent Posts

  • PCR OG Elisa Kit
  • Phosphocreatine (PCR) EN Elisa Kit
  • PCR I Elisa
  • The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer
  • Developing a Web-Based Shared Decision-Making Tool for Fertility Preservation Among Reproductive-Age Women With Breast Cancer: An Action Research Approach

Tags

antibodies covid antibodies covid 19 antibodies decline antibodies definition antibodies fade antibodies fading antibodies for coronavirus antibodies for coronavirus immunity antibodies immunity study antibodies in blood antibodies in blood test antibodies in saliva antibodies joke antibodies medical meaning antibodies movie antibodies online antibodies test antibodies test covid serums.com serums for sensitive skin serums for wrinkles serums in anoka serums in anoka mn serums mn serums osrs serums peru serumstat serums ulta serums vs creams serums with glycerin serums with spf virus cases in dyer county tenn virus cases in florida virus cases in texas virus cases in wv virus count virus deaths virus deaths by state virus in florida virus in ohio virus map virus masks virus news virus numbers virus protection
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« Feb    
Categories
  • 4 Host
  • 96T
  • array
  • Assay
  • Blocking
  • Blog
  • Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool.
  • Main
  • Positive
  • precipitation
  • Premix
  • Preps
  • primers
  • probe
  • profile
  • profiling
  • Pure
  • Purification
  • purified
  • Quantile regression for survival data in modern cancer research: expanding statistical tools for precision medicine.
  • Rabbit
  • Recombinant
  • The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research.
Recent Posts
  • PCR OG Elisa Kit
  • Phosphocreatine (PCR) EN Elisa Kit
  • PCR I Elisa
  • The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer
  • Developing a Web-Based Shared Decision-Making Tool for Fertility Preservation Among Reproductive-Age Women With Breast Cancer: An Action Research Approach
Tags
antibodies covid antibodies covid 19 antibodies decline antibodies definition antibodies fade antibodies fading antibodies for coronavirus antibodies for coronavirus immunity antibodies immunity study antibodies in blood antibodies in blood test antibodies in saliva antibodies joke antibodies medical meaning antibodies movie antibodies online antibodies test antibodies test covid serums.com serums for sensitive skin serums for wrinkles serums in anoka serums in anoka mn serums mn serums osrs serums peru serumstat serums ulta serums vs creams serums with glycerin serums with spf virus cases in dyer county tenn virus cases in florida virus cases in texas virus cases in wv virus count virus deaths virus deaths by state virus in florida virus in ohio virus map virus masks virus news virus numbers virus protection
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« Feb    

Copyright © 2026 | WordPress Theme by MH Themes